AMUNDI ASSET MANAGEMENT US, INC. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 335 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMUNDI ASSET MANAGEMENT US, INC. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$247,000
-52.6%
5,929
-51.4%
0.00%
Q4 2020$521,000
+62.3%
12,2000.0%0.00%
Q3 2020$321,000
-1.8%
12,2000.0%0.00%
Q2 2020$327,000
+49.3%
12,2000.0%0.00%
Q1 2020$219,000
+1.4%
12,2000.0%0.00%
Q4 2019$216,000
+14.3%
12,2000.0%0.00%
Q3 2019$189,000
+14.5%
12,200
+27.1%
0.00%
Q2 2019$165,000
+6.5%
9,6000.0%0.00%
Q1 2019$155,000
+10.7%
9,6000.0%0.00%
Q4 2018$140,0009,6000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Third Security, LLC 14,092,771$256,066,00016.64%
BB BIOTECH AG 8,247,860$149,864,0003.97%
MSD Partners, L.P. 2,245,000$40,792,0003.07%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 428,633$5,969,0002.84%
First Light Asset Management, LLC 885,523$16,090,0002.60%
SNYDER CAPITAL MANAGEMENT L P 2,387,350$43,378,0001.93%
Sterling Global Strategies LLC 22,000$400,0001.74%
Taylor Wealth Management Partners 221,380$4,022,0001.71%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,228,399$167,680,0001.68%
DOHENY ASSET MANAGEMENT /CA 124,393$2,260,0001.18%
View complete list of HALOZYME THERAPEUTICS INC shareholders